FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Paytm IPO and Tatva Chintan Pharma IPO.
Paytm IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Paytm IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Citigroup Global Markets India Private Limited Goldman Sachs (India) Securities Private Limited Hdfc Bank Limited ICICI Securities Limited J.P. Morgan India Private Limited Morgan Stanley India Company Pvt Ltd |
ICICI Securities Limited Jm Financial Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.
Paytm IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹2,080.00 per share | ₹1,073.00 per share |
Issue Price (Upper) | ₹2,150.00 per share | ₹1,083.00 per share |
Issue Price (Final) | ₹2,150.00 per share | ₹1,083.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 6 shares | 13 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹8,300.00 Cr | up to ₹225.00 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | up to ₹10,000.00 Cr | up to ₹275.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹18,300.00 Cr | up to ₹500.00 Cr |
Paytm IPO opens on Nov 08, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Paytm IPO and Tatva Chintan Pharma IPO is Nov 10, 2021, and Jul 20, 2021, respectively.
Paytm IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Nov 08, 2021 | Jul 16, 2021 |
Issue Close | Nov 10, 2021 | Jul 20, 2021 |
Basis Of Allotment (Tentative) | Nov 15, 2021 | Jul 26, 2021 |
Initiation of Refunds (Tentative) | Nov 16, 2021 | Jul 27, 2021 |
Credit of Share (Tentative) | Nov 17, 2021 | Jul 28, 2021 |
Listing date (Tentative) | Nov 18, 2021 | Jul 29, 2021 |
Anchor Lockin End date 1 | Dec 15, 2021 | Aug 25, 2021 |
Anchor Lockin End date 2 | Feb 13, 2022 | Oct 24, 2021 |
Paytm IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .
Paytm IPO | Tatva Chintan Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 79.17% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Paytm IPO retail investors (RII) are offered 87,98,076 shares while in Tatva Chintan Pharma IPO retail investors are offered 87,98,076 shares. Qualified institutional buyers (QIB) are offered 2,63,94,231 shares in Paytm IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.
Paytm IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 2,63,94,231 shares | 9,31,966 shares |
NII | 1,31,97,115 shares | 6,98,975 shares |
RII | 87,98,076 shares | 16,30,941 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 4,83,89,422 shares | 32,61,882 shares |
Paytm IPO subscribed 1.89x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.
Paytm IPO | Tatva Chintan Pharma IPO | |
---|---|---|
QIB (times) | 2.79x | 185.23x |
NII (times) | 0.24x | 512.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.66x | 35.35x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.89x | 180.36x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|